Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07700329
PHASE1

A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants

Sponsor: Celgene

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate the drug levels, safety and tolerability of BMS-986368 in healthy Chinese participants

Official title: A Phase 1, Double-Blinded, Randomized, Placebo-Controlled, Two Parallel Cohort Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2027-01-05

Completion Date

2027-02-23

Last Updated

2026-07-14

Healthy Volunteers

Yes

Interventions

DRUG

BMS-986368

Specified dose on specified days

OTHER

BMS-986368-matching Placebo

Specified dose of specified days